Clinical Trials & Results

Find a Trial or Results of a Completed Trial

Filter

Health Condition

Toggle

Study Status

Toggle

Age group

Toggle

Gender

Toggle

Phase

Toggle

Study Types

Toggle

Showing 20 of 229 Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Study ID: 116B8 | 2009-010562-31

inflammation and infections icon for clinical trials
Condition(s):
Stable Renal Transplant Recipients
Status:
Terminated
Requirements:
18 Years and older
Interventions:
Drug: mycophenolate mofetil (Myfenax) | Drug: mycophenolate mofetil (Cellcept)

Study ID: 9006

neurology icon for clinical trials
Condition(s):
Relapse-Remitting Multiple Sclerosis
Status:
Completed
Requirements:
18 Years to 50 Years
Interventions:
Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 40 mg

Study ID: 9013

neurology icon for clinical trials
Condition(s):
Relapsing Remitting Multiple Sclerosis
Status:
Terminated
Requirements:
18 Years to 50 Years
Interventions:
Drug: Glatiramer Acetate | Drug: Betaseron | Drug: Rebif

Study ID: ABM-AS-307

Condition(s):
Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Emphysema | Chronic Bronchitis
Status:
Completed
Requirements:
4 Years and older
Interventions:
Drug: Albuterol

Study ID: ABS-AS-101

Condition(s):
Asthma
Status:
Completed
Requirements:
18 Years to 45 Years
Interventions:
Drug: Albuterol dry powder inhaler | Drug: Albuterol HFA MDI (hydrofluoroalkane metered dose inhaler)

Study ID: ABS-AS-102

Condition(s):
Asthma
Status:
Completed
Requirements:
4 Years to 11 Years
Interventions:
Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA

Study ID: ABS-AS-201

Condition(s):
Asthma
Status:
Completed
Requirements:
12 Years and older
Interventions:
Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler

Study ID: ABS-AS-202

Condition(s):
Asthma
Status:
Completed
Requirements:
4 Years to 11 Years
Interventions:
Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo

Study ID: ABS-AS-30064

Condition(s):
Asthma
Status:
Completed
Requirements:
18 Years and older
Interventions:
Drug: Albuterol Sulfate

Study ID: ABS-AS-301

Condition(s):
Asthma
Status:
Completed
Requirements:
12 Years and older
Interventions:
Drug: Placebo MDPI | Drug: Albuterol MDPI

Study ID: ABS-AS-302

Condition(s):
Exercise-Induced Bronchoconstriction (EIB)
Status:
Completed
Requirements:
18 Years to 50 Years
Interventions:
Drug: Albuterol Spiromax | Drug: Placebo Spiromax

Study ID: ABS-AS-303

Condition(s):
Asthma
Status:
Completed
Requirements:
4 Years to 11 Years
Interventions:
Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler

Study ID: ABS-AS-304

Condition(s):
Asthma
Status:
Completed
Requirements:
12 Years and older
Interventions:
Drug: Placebo MDPI | Drug: Albuterol MDPI

Study ID: ABS-AS-306

Condition(s):
Asthma
Status:
Terminated
Requirements:
12 Years and older
Interventions:
Drug: Placebo Spiromax | Drug: Albuterol Spiromax

Study ID: ABS-AS-307

Condition(s):
Asthma
Status:
Completed
Requirements:
12 Years and older
Interventions:
Drug: Placebo MDPI | Drug: Albuterol MDPI

Study ID: ABS-AS-308

Condition(s):
Asthma | Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Requirements:
4 Years and older
Interventions:
Drug: Albuterol Spiromaxֲ®

Study ID: ABS-AS-40138

Condition(s):
Asthma
Status:
Completed
Requirements:
13 Years and older
Interventions:
Drug: Albuterol eMDPI DS | Drug: albuterol

Study ID: ABS-COPD-30065

Condition(s):
Chronic Obstructive Pulmonary Disease
Status:
Completed
Requirements:
40 Years and older
Interventions:
Drug: Albuterol sulfate (ABS)

Study ID: ACR16 C008

neurology icon for clinical trials
Condition(s):
Huntington's Disease
Status:
Completed
Requirements:
30 Years and older
Interventions:
Drug: ACR16 | Drug: Placebo

Study ID: ACR16 C009

neurology icon for clinical trials
Condition(s):
Huntington Disease
Status:
Completed
Requirements:
30 Years and older
Interventions:
Drug: ACR16 10 mg | Drug: ACR16 22.5 mg | Drug: ACR16 45 mg | Other: Placebo